CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.68
-0.08 (-10.11%)
As of Nov 6, 2:11 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 7 58%
Hold 5 42%
Sell 0 0%
Price Target
Analyst Price Target +3,377.9% upside
Low Target $17.63
Average Target $23.50
High Target $33.45
Current Price $0.68
Current
$0.68
Target
$23.50
$17.63 $23.50 avg $33.45
Scenario Analysis
Bear Case
$17.63
2,509.1%
Low target
Base Case
$23.50
+3,377.9%
Avg target
Bull Case
$33.45
+4,850.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$3.28
-79.4% from high
52-Week Low
$0.91
+-25.7% from low
Target vs 52W High
$23.50
+616.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%